Results 251 to 260 of about 19,188,679 (307)

Real-world second-line treatment pattern for unresectable or advanced hepatic carcinoma in China: a retrospective database study. [PDF]

J Gastrointest Oncol
Leng J, Wu J, Han R, Wei H, Chen K.
europepmc   +1 more source

Sunitinib as Second-Line Treatment in Advanced Intrahepatic Cholangiocarcinoma: Results From the SUN-CK GERCOR Phase II Trial. [PDF]

Liver Int
Gros L, Bouattour M, Dumont C, Dahan L, Malka D, Tijeras-Raballand A, De Gramont A, Ronot M, Dreyer C, Neuzillet C, Bourget P, Hadengue A, Roldan N, Garcia-Larnicol ML, Chibaudel B, Raymond E, Faivre S.   +16 more
europepmc   +1 more source

Lenvatinib <i>vs.</i> sorafenib as second-line treatment post atezolizumab plus bevacizumab for hepatocellular carcinoma: The LEVIATHAN study. [PDF]

JHEP Rep
Lombardi P, Kim JS, Manfredi GF, Celsa C, Fulgenzi CAM, D'Alessio A, Stefanini B, Doshi NC, Warmington E, Marron TU, Pinter M, Scheiner B, Kang B, Lim HY, Hsu WF, Wietharn B, Silletta M, Parisi A, Lin CY, Dalbeni A, Masi G, Schönlein M, von Felden J, Piscaglia F, Galle PR, Kudo M, Pressiani T, Rimassa L, Pirisi M, Cabibbo G, Chon HJ, Pinato DJ.   +31 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Second-line treatment in seronegative spondylarthropathies

Seminars in Arthritis and Rheumatism, 1994
The literature concerning second-line treatment of seronegative spondylarethropathies from 1940 to August 1993 was reviewed. Sulfasalazine appeared to be effective in the treatment of ankylosing spondylitis (AS) and promising in reactive arthritis (ReA) and Reiters' syndrome (RS).
M C, Creemers, P L, van Riel, M J, Franssen, L B, van de Putte, F W, Gribnau   +4 more
openaire   +2 more sources

Second line treatment options for pancreatic cancer

Expert Opinion on Pharmacotherapy, 2017
Patients with advanced pancreatic cancer (APC) refractory to first-line therapy have a dismal prognosis and limited therapeutic options, with only one option consisting of nanoliposomal irinotecan in combination with fluorouracil and folinic acid which was approved by FDA based upon results of the phase III NAPOLI-1 study. Areas covered: We performed a
Frank C, Passero, Muhammad Wasif, Saif
openaire   +2 more sources

First and second line treatment - A Retrospective View

Journal of the Royal Army Medical Corps, 2007
The case history of a single casualty is recorded. A critique of aspects of his treatment is presented. Some suggestions for modifying aspects of his treatment are considered. A factual account of the wounds received by a soldier during one of the land battles in the Falklands Campaign is presented together with an account of his initial (first and ...
D S, Jackson, M D, Jowitt, R J, Knight
openaire   +2 more sources

Second-line treatment for malignant pleural mesothelioma

Cancer Treatment Reviews, 2010
Most patients affected by malignant pleural mesothelioma (MPM) are candidates for chemotherapy during the course of the disease, as single modality treatment or within the context of a multimodality approach. Following the results of a large phase III trial, the combination of cisplatin and pemetrexed has become the preferred first-line chemotherapy ...
Giovanni Luca, Ceresoli, Paolo Andrea, Zucali, Letizia, Gianoncelli, Elena, Lorenzi, Armando, Santoro   +4 more
openaire   +2 more sources

Second-line treatment of postpartum haemorrhage (PPH)

Archives of Gynecology and Obstetrics, 2012
Postpartum haemorrhage (PPH) remains to be the most common cause of maternal mortality and is responsible for 25 % of the maternal deaths worldwide. Although the absolute risk of maternal death is much lower, a recent increase of PPH and related maternal adverse outcomes has been noted in high-income countries as well.
W, Rath, A, Hackethal, M K, Bohlmann
openaire   +2 more sources

Second‐line treatment in invasive mould infections

Mycoses, 2006
AbstractA prevalence of up to 30% of invasive fungal infections (IFI) has been reported from autopsy studies in patients treated for haematological malignancies. Despite substantial advances in the last decade, IFI are still associated with a mortality of up to more than 70%, in particular for those patients suffering from invasive aspergillosis.
Meinolf, Karthaus, Oliver A, Cornely
openaire   +2 more sources